Diabetes and stroke: An important complication

被引：25

作者：

Bloomgarden, Zachary ^{[1
]}

Chilton, Robert ^{[2
]}

机构：

[1] Icahn Sch Med Mt Sinai, Div Endocrinol, New York, NY 10029 USA

[2] Univ Texas Hlth Sci Ctr San Antonio, Div Cardiol, San Antonio, TX 78229 USA

来源：

JOURNAL OF DIABETES | 2021年 / 13卷 / 03期

关键词：

ACUTE ISCHEMIC-STROKE; GLUCOSE CONTROL; RISK-FACTORS; ATRIAL-FIBRILLATION; BLOOD-PRESSURE; TYPE-2; METAANALYSIS; OUTCOMES; IMPACT; SULFONYLUREAS;

D O I：

10.1111/1753-0407.13142

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：184 / 190

页数：7

共 63 条

[1]

Does the presence of diabetes mellitus confer an increased risk of stroke in patients with atrial fibrillation on direct oral anticoagulants? A systematic review and meta-analysis [J].

Abdool, Mohammad ;

Kunutsor, Setor K. ;

Khunti, Kamlesh ;

Seidu, Samuel .

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (06) :1725-1733

[2]

The Impact of Diabetes on Outcomes After Acute Ischemic Stroke: A Prospective Observational Study [J].

Akhtar, Naveed ;

Kamran, Saadat ;

Singh, Rajvir ;

Malik, Rayaz A. ;

Deleu, Dirk ;

Bourke, Paula J. ;

Joseph, Sujatha ;

Santos, Mark D. ;

Morgan, Deborah M. ;

Wadiwala, Faisal M. ;

Francis, Reny ;

Babu, Blessy M. ;

George, Pooja ;

Ibrahim, Rumissa ;

Garcia-Bermejo, Pablo ;

Shuaib, Ashfaq .

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2019, 28 (03) :619-626

[3]

Potential Therapeutic Effects of Sodium Glucose-linked Cotransporter 2 Inhibitors in Stroke [J].

Al Hamed, Fatima Alzahra ;

Elewa, Hazem .

CLINICAL THERAPEUTICS, 2020, 42 (11) :E242-E249

[4]

Advantages of Phosphodiesterase Type 5 Inhibitors in the Management of Glucose Metabolism Disorders: A Clinical and Translational Issue [J].

Antinozzi, Cristina ;

Sgro, Paolo ;

Di Luigi, Luigi .

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2020, 2020

[5]

REWIND to fast forward: time to revisit stroke prevention in type 2 diabetes? [J].

Aroda, Vanita .

LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (02) :90-92

[6]

A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications [J].

Babel, Rishabh A. ;

Dandekar, Manoj P. .

CURRENT DIABETES REVIEWS, 2021, 17 (04) :457-473

[7]

Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data [J].

Bain, Steve ;

Druyts, Eric ;

Balijepalli, Chakrapani ;

Baxter, Carl A. ;

Currie, Craig J. ;

Das, Romita ;

Donnelly, Richard ;

Khunti, Kamlesh ;

Langerman, Haya ;

Leigh, Paul ;

Siliman, Gaye ;

Thorlund, Kristian ;

Toor, Kabirraaj ;

Vora, Jiten ;

Mills, Edward J. .

DIABETES OBESITY & METABOLISM, 2017, 19 (03) :329-335

[8]

Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study [J].

Bebu, Ionut ;

Schade, David ;

Braffett, Barbara ;

Kosiborod, Mikhail ;

Lopes-Virella, Maria ;

Soliman, Elsayed Z. ;

Herman, William H. ;

Bluemke, David A. ;

Wallia, Amisha ;

Orchard, Trevor ;

Lachin, John M. .

DIABETES CARE, 2020, 43 (04) :867-874

[9]

Stroke in the patient with diabetes (Part 2) ? Prevention and the effects of glucose lowering therapies [J].

Bell, David S. H. ;

Goncalves, Edison .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 164

[10]

Insulin for glycaemic control in acute ischaemic stroke [J].

Bellolio, M. Fernanda ;

Gilmore, Rachel M. ;

Ganti, Latha .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (01)

← 1 2 3 4 5 6 7 →